Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development

Clinical Pharmacology and Therapeutics

Volumn 73, Issue 4, 2003, Pages 284-291

  Rolan, Paul ^a   Atkinson Jr , Arthur J ^b   Lesko, Lawrence J ^b  

^a Medeval Ltd   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL PRACTICE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; HEALTH CARE POLICY; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS; CONGRESSES; DRUG DESIGN; EUROPE; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGY;

EID: 0037384066     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(02)17625-9     Document Type: Conference Paper

References (24)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
2. Lesko LJ, Atkinson AJ Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Ann Rev Pharmacol Toxicol 2001;41:347-66.
3. De Gruttola VG, Clax P, DeMets DL, et al. Considerations in the evaluation of surrogate endpoints in clinical trials: summary of a National Institutes of Health workshop. Control Clin Trials 2001;22:485-502.
4. Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA 1999;282:790-5.
5. Breimer DD, Danhof M. Relevance of pharmacokinetic-pharmacodynamic modeling concepts in drug development. The "Wooden Shoe" paradigm. Clin Pharmacokinet 1997;32:259-67.
6. Ballet F. Hepatotoxicity in drug development: detection, significance and solutions. J Hepatol 1997;26(Suppl 2): 26-36.
7. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-75.
8. West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998;97:1440-5.
9. Physicians' desk reference. 56th ed. Montvale (NJ): Medical Economics; 2002, p. 1415.
10. Kuivenhoven JA, Jukema JW, Zwinderman AJ, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 1998;338:86-93.
11. Aicher L, Wahl D, Arce A, Grenet O, Steiner S. New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis 1998;19:1998-2003.
12. Bichsel VE, Liotta LA, Petricoin EF. Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J 2001;7:69-78.
13. Echt DS, Liebson PR, Mitchell B, CAST Investigators. Mortality and morbidity of patients receiving encainide, flecainide or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991;324:781-8.
14. Jang LJ, Ko HC, Peck C, Schaefer HG. PK/PD modeling of moxonidine and simulation of a phase 3 trial [abstract]. Clin Pharmacol Ther 2000;67:125.
15. Coats AJS. Heart failure 99 - the Moxcon story. Int J Cardiol 1999;71:109-11.
16. Steiner S, Anderson NL. Pharmaceutical proteomics. Ann N Y Acad Sci 2000;919:48-51.
17. Physiome Sciences, Inc, Web site. Available at: http://www.physiome.com. Accessed Feb 27, 2003.
18. Entelos, Inc, Web site. Available at: http://www.entelos.com. Accessed Feb 27, 2003.
19. Laughlin R, Pines D. The theory of everything. Proc Natl Acad Sci U S A 2000;97:28-31.
20. Roberts G. Protein chips - delivering on the promise of genomics. Scrip Magazine 2001;99:12.
21. Amato I. Fomenting a revolution, in miniature. Science 1998;282:402-3,405.
22. Wang L. Getting nanowired: makers of nanowires may overcome the limits that loom for microchip fabrication. Sci News 2001;159:286-7.
23. Gibbs WW. Cybernetic cells. Sci Am 2001;285:52-7.
24. Goldin DS, Dahl CA, Olsen KL, Ostrach LH, Klausner RD. The NASA-NCI collaboration on biomolecular sensors. Science 2001;292:443-4.